Literature DB >> 21917678

The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma.

Bryan L Betz1, Michael H Roh, Helmut C Weigelin, Jeremiah B Placido, Lindsay A Schmidt, Sara Farmen, Doug A Arenberg, Gregory P Kalemkerian, Stewart M Knoepp.   

Abstract

EGFR and KRAS mutation analyses are of increasing importance for guiding the treatment of non-small cell lung carcinomas. Insufficient cellularity of cell blocks can represent an impediment to the performance of these tests. We investigated the usefulness of cytologic direct smears as an alternative specimen source for mutation testing. Tumor cell-enriched areas from freshly prepared and archived rapid Romanowsky-stained direct smears in 33 cases of lung carcinoma were microdissected for DNA isolation and evaluated for EGFR and KRAS mutations. EGFR mutations were detected in 3 adenocarcinomas; 2 tumors had the L858R substitution and 1 an exon 19 deletion. KRAS mutations affecting codon 12, 13, or 61 were detected in 11 cases (8 adenocarcinomas and 3 non-small cell carcinomas). EGFR and KRAS mutations were mutually exclusive. Hence, archived and freshly prepared direct smears represent a robust and valuable specimen source for molecular studies, especially when cell blocks exhibit insufficient cellularity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917678     DOI: 10.1309/AJCP84TUTQOSUONG

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

2.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  Arch Pathol Lab Med       Date:  2013-04-03       Impact factor: 5.534

3.  FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.

Authors:  Amanda L Treece; Nathan D Montgomery; Nirali M Patel; Chris J Civalier; Leslie G Dodd; Margaret L Gulley; Jessica K Booker; Karen E Weck
Journal:  Cancer Cytopathol       Date:  2016-02-16       Impact factor: 5.284

Review 4.  The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing.

Authors:  Michael H Roh
Journal:  J Pathol Transl Med       Date:  2015-07-15

5.  Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations.

Authors:  Mei Li; Qiuping Zhang; Lina Liu; Weipeng Lu; Hong Wei; Rachel W Li; Shen Lu
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

6.  Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Authors:  Wenbin Li; Zhihui Zhang; Lei Guo; Tian Qiu; Yun Ling; Jian Cao; Huiqin Guo; Huan Zhao; Lin Li; Jianming Ying
Journal:  Oncotarget       Date:  2016-02-16

7.  Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.

Authors:  Wei Wu; Ziyang Cao; Wei Zhang; Liping Zhang; Likun Hou; Chunyan Wu
Journal:  Diagn Pathol       Date:  2020-01-31       Impact factor: 2.644

Review 8.  EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

Authors:  Gillian Ellison; Guanshan Zhu; Alexandros Moulis; Simon Dearden; Georgina Speake; Rose McCormack
Journal:  J Clin Pathol       Date:  2012-11-21       Impact factor: 3.411

Review 9.  Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies.

Authors:  Hui Chen; Rajyalakshmi Luthra; Rashmi S Goswami; Rajesh R Singh; Sinchita Roy-Chowdhuri
Journal:  Cancers (Basel)       Date:  2015-08-28       Impact factor: 6.639

10.  Destaining of Diff-Quik stained cytologic smears is not necessary for the detection of anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma by fluorescence in situ hybridization.

Authors:  Weisheng Xu; Kamal K Khurana; Jamie Tull; Charlene Maciak; Shengle Zhang
Journal:  J Cytol       Date:  2016 Jul-Sep       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.